Humboldt β Full Portfolio
20 tracked investments Β· listed companies and verified rows first
Berkeley, US
Brian Thomas(Executive Officer, Director, Promoter)
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Board seatSebastian BernalesΒ· per SEC Form D Β· $100M raise Β· filed Jan 2023
Co-investorsVHM
HealthtechSan Leandro, US
Zachary Sun(Executive Officer, Director)Michael Nemzek(Executive Officer, Director)Corinna Chen(Director)
Board seatFrancisco DopazoΒ· per SEC Form D Β· $17.6M raise Β· filed Sep 2023
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalOlive Tree Capital
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Lin-Arlow(Executive Officer, Director)Daniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)
BoardYanniv Dorone(Director)
Co-investorsCarbon SiliconDauntless VenturesFifty YearsMetaplanetY CombinatorFall Line Capital+2 more
Co-investorsAgFunderAngel Collective Opportunity FundArgonautic VenturesFifty YearsGermin8 VenturesHorizons Ventures+3 more
Cellineobio develops cell engineering and bioprocess technology platforms.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)Nabiha Saklayen(Executive Officer, Director)Matthias Wagner(Executive Officer, Director)
Co-investors8VCFelicis VenturesKhosla VenturesThe Engine Ventures
Debut develops an AI-powered biomanufacturing platform that uses genomics and biotechnology to discover, validate, and scale novel bioactive ingredients for the beauty industry, including skincare, hair, and body care products.
AI & Machine LearningBiotechConsumerDeep TechSan Diego, US
Joshua Britton(Founder)
Co-investorsGS FuturesMaterial ImpactBreakout VenturesKdT VenturesSandbox IndustriesACVC Partners+8 more
Endpoint Health develops therapeutics and therapy-guiding diagnostic tests personalized to each patient's biology for immune-driven critical and chronic illnesses such as sepsis, ARDS, rheumatoid arthritis and inflammatory bowel disease.
BiotechDigital HealthHealthtech
Co-investorsWireframe Ventures
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)Matt Blischak(Chief Executive Officer)R. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsB3 HoldingOctave Ventures LlcOCV PartnersOMX VenturesShumway Capital
Finless Foods develops cell-cultivated seafood alternatives, starting with Pacific bluefin tuna, aimed at consumers seeking sustainable options that reduce pressure on wild fish stocks.
BiotechClimate TechFoodTech
Brandon Chen(Co-Founder & CEO)Brian Wyrwas(Co-Founder & CSO)Michael Selden(Co-Founder & Advisor)
Co-investorsAt One VenturesAurum Venture PartnersBabel VenturesBlue Horizon CorporationBlue Revolution Investments G.P.Endurance28+7 more
GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFomeβ’ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling.
AI & Machine LearningBiotechMedical DevicesCambridge, US
George Church(Co-Founder & Scientific Advisor)Parastoo Khoshakhlagh(Chief Executive Officer & Co-Founder)Alex Ng(Chief Innovation Officer & Co-Founder)
Co-investorsAndreessen HorowitzGlobal BrainMedical Excellence Capital
Geltor develops biodesigned proteins, including collagen products such as PrimaColl, used as active ingredients in cosmetics and personal care formulations.
BiotechNew MaterialsWellness & Fitness
Co-investorsAgronomicsAlwyn CapitalArgonautic VenturesBaruch Future VenturesBlue Horizon CorporationCavallo Ventures+12 more
Co-investorsBackedHAWKTAILFuture Positive Capital
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical Devices
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent Capital
Co-investorsID345Sun Mountain CapitalOS Fund
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)
BoardDavid Bowman(Director)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Blue Ledge CapitalJoyance Partners+6 more
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Director)Michael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)
BoardKiersten Stead(Director)inThomas Grotkjaer(Director)
Co-investorsDCVC (Data Collective)Hemisphere Ventures LLCWireframe Ventures8VCAgFunderDCVC Bio+3 more
Phage Lab develops solutions to address bacterial outbreaks using a One Health approach, bringing together around 100 scientists and professionals from multiple disciplines in animal health and microbiology.
AgTechAI & Machine LearningBiotech
Pablo Cifuentes Palma(Founder)inHans Pieringer(Founder)in
Co-investorsCollaborative FundInvexor Venture PartnersNazcaThe Yield Lab LatamKaszek Ventures
Co-investorsSustainable Food VenturesCleveland AvenueMAYA Capital VenturesTrousdale Ventures
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactKdT Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.



